Reduced Physical Activity With Bronchiectasis

References

1. 1.↵
   1. Barker AF

   . Bronchiectasis. N Engl J Med 2002;346(18):1383–1393.

   OpenUrlCrossRefPubMedWeb of Science
2. 2.
   1. Davies RJ

   1. Cole PJ

   . A new look at the pathogenesis and management of persistent bronchial sepsis: a “vicious cycle” hypothesis and its logical therapeutic connotations. In Davies RJ, editor. Strategies for the management of chronic bronchial sepsis: Proceedings of a symposium held at the Charing Cross Hospital. London: Medical Education Services. 1984;12:1–20.

   OpenUrl
3. 3.↵
   1. Chang AB,
   2. Bilton D

   . Exacerbations in cystic fibrosis: non-cystic fibrosis bronchiectasis. Thorax 2008;63(3):269–276.

   OpenUrlAbstract/FREE Full Text
4. 4.↵
   1. Drain M,
   2. Elborn SJ

   . Assessment and investigation of adults with bronchiectasis. Eur Respir Mon 2011;52:32–43.

   OpenUrl
5. 5.↵
   1. King PT,
   2. Holdsworth SR,
   3. Freezer NJ,
   4. Villanueva E,
   5. Farmer MW,
   6. Guy P,
   7. Holmes PW

   . Lung diffusing capacity in adult bronchiectasis: a longitudinal study. Respir Care 2010;55(12):1686–1692.

   OpenUrlAbstract/FREE Full Text
6. 6.↵
   1. de Camargo AA,
   2. Amaral TS,
   3. Rached SZ,
   4. Athanazio RA,
   5. Lanza FC,
   6. Sampaio LM,
   7. et al

   . Incremental shuttle walking test: a reproducible and valid test to evaluate exercise tolerance in adults with noncystic fibrosis bronchiectasis. Arch Phys Med Rehabil 2014;95(5):892–899.

   OpenUrlPubMed
7. 7.↵
   1. Bradley JM,
   2. Wilson JJ,
   3. Hayes K,
   4. Kent L,
   5. McDonough S,
   6. Tully MA,
   7. et al

   . Sedentary behaviour and physical activity in bronchiectasis: a cross-sectional study. BMC Pulm Med 2015;15:61.

   OpenUrlCrossRefPubMed
8. 8.↵
   1. Wilson JJ,
   2. Kirk A,
   3. Hayes K,
   4. Bradbury I,
   5. McDonough S,
   6. Tully MA,
   7. et al

   . Applying the transtheoretical model to physical activity behavior in individuals with bronchiectasis. Respir Care 2016;61(1):68–77.

   OpenUrlAbstract/FREE Full Text
9. 9.↵
   1. Pitta F,
   2. Breyer MK,
   3. Hernandes NA,
   4. Teixeira D,
   5. Sant'Anna TJP,
   6. Fontana AD,
   7. et al

   . Comparison of daily physical activity between COPD patients from Central Europe and South America. Respir Med 2009;103:421–426.

   OpenUrlCrossRefPubMed
10. 10.↵
    1. Watz H,
    2. Pitta F,
    3. Rochester CL,
    4. Garcia-Aymerich J,
    5. ZuWallack R,
    6. Troosters T,
    7. et al

    . An official European Respiratory Society statement on physical activity in COPD. Eur Respir J 2014;44:1521–1537.

    OpenUrlAbstract/FREE Full Text
11. 11.↵
    1. Sandland CJ,
    2. Singh SJ,
    3. Cursio A,
    4. Jones PM,
    5. Morgan MD

    . A profile of daily activity in chronic obstructive pulmonary disease. J Cardiopulm Rehabil 2005;25(3):181–183.

    OpenUrlCrossRefPubMed
12. 12.↵
    1. Athanazio RA,
    2. Rached SZ,
    3. Rohde C,
    4. Pinto RC,
    5. Fernandes FLA,
    6. Stelmach R

    . Should the bronchiectasis treatment given to cystic fibrosis patients be extrapolated to those with bronchiectasis from other causes? J Bras Pneumol 2010;36(4):425–431.

    OpenUrlPubMed
13. 13.↵
    Sociedade Brasileira de Pneumologia e Tisiologia. Diretrizes para testes de função pulmonar. J Pneumol 2002;28(Suppl 3):iii1–iii82.

    OpenUrl
14. 14.↵
    1. Pereira CAC,
    2. Sato T,
    3. Rodrigues SC

    . New reference values for forced spirometry in white adults in Brazil. J Bras Pneumol 2007;33(4):397–406.

    OpenUrlCrossRefPubMed
15. 15.↵
    1. Singh SJ,
    2. Morgan MD,
    3. Scott S,
    4. Walters D,
    5. Hardman AE

    . Development of a shuttle walking test of disability in patients with chronic airways obstruction. Thorax 1992;47(12):1019–1024.

    OpenUrlAbstract/FREE Full Text
16. 16.↵
    1. Borg GA

    . Psychophysical bases of perceived exertion. Med Sci Sports Exerc 1982;14(5):377–381.

    OpenUrlCrossRefPubMedWeb of Science
17. 17.↵
    1. Probst VS,
    2. Hernandes NA,
    3. Teixeira DC,
    4. Felcar JM,
    5. Mesquita RB,
    6. Gonçalves CG,
    7. et al

    . Reference values for the incremental shuttle walking test. Respir Med 2012;106(2):243–348.

    OpenUrlCrossRefPubMed
18. 18.↵
    1. Kovelis D,
    2. Segretti NO,
    3. Probst VS,
    4. Lareau SC,
    5. Brunetto AF,
    6. Pitta F

    . Validation of the Modified Pulmonary Functional Status and Dyspnea Questionnaire and the Medical Research Council scale for use in Brazilian patients with chronic obstructive pulmonary disease. J Bras Pneumol 2008;34(12):1008–1018.

    OpenUrlPubMed
19. 19.↵
    1. Le Masurier GC,
    2. Lee SM,
    3. Tudor-Locke C

    . Motion sensor accuracy under controlled and free-living conditions. Med Sci Sports Exerc 2004;36(5):905–910.

    OpenUrlPubMedWeb of Science
20. 20.↵
    1. Cain KL,
    2. Sallis JF,
    3. Coway TL,
    4. Dyck DV,
    5. Calhoon L

    . Using accelerometers in youth physical activity studies: a review of methods. J Phys Act Health 2013;10(3):437–450.

    OpenUrlCrossRefPubMed
21. 21.↵
    1. Tudor-Locke C,
    2. Hatano Y,
    3. Pangrazi RP,
    4. Kang M

    . Revisiting “how many steps are enough?” Med Sci Sports Exerc 2008;40(Suppl 7):iii537–iii543.

    OpenUrl
22. 22.↵
    1. Koulouris NG,
    2. Retsou S,
    3. Kosmas E,
    4. Dimakou K,
    5. Malagari K,
    6. Mantzikopoulos G,
    7. et al

    . Tidal expiratory flow limitation, dyspnoea and exercise capacity in patients with bilateral bronchiectasis. Eur Respir J 2003;21(5):743–748.

    OpenUrlAbstract/FREE Full Text
23. 23.↵
    1. Préfaut C,
    2. Varray A,
    3. Vallet G

    . Pathophysiological basis of exercise training in patients with chronic obstructive lung disease. Eur Respir Rev 1995;5(25):27–32.

    OpenUrl
24. 24.↵
    1. Ferreira CAS,
    2. Stelmach R,
    3. Feltrin MIZ,
    4. Filho WJ,
    5. Chiba T,
    6. Cukier A

    . Evaluation of health-related quality of life in low-income patients with COPD receiving long-term oxygen therapy. CHEST 2003;123(1):136–141.

    OpenUrlCrossRefPubMedWeb of Science
25. 25.↵
    1. García-Rivero JL,
    2. Esquinas C,
    3. Barrecheguren M,
    4. Bonnin-Vilaplana M,
    5. García-Sidro P,
    6. Herrejón A

    . Risk factors of poor outcomes after admission for a COPD exacerbation: multivariate logistic predictive models. COPD 2017;14(2):164–169.

    OpenUrl
26. 26.↵
    1. Carone M,
    2. Antoniu S,
    3. Baiardi P,
    4. Digilio VS,
    5. Jones PW,
    6. Bertolotti G

    ; QuESS Group. Predictors of mortality in patients with COPD and chronic respiratory failure: the quality-of-life evaluation and survival study (QuESS): a three-year study. COPD 2016;13(2):130–138.

    OpenUrl
27. 27.↵
    1. Waschki B,
    2. Kirsten A,
    3. Holz O,
    4. Müller K-C,
    5. Meyer T,
    6. Watz H,
    7. et al

    . Physical activity is the strongest predictor of all-cause mortality in patients with COPD: a prospective cohort study. Chest 2011;140(2):331–342.

    OpenUrlCrossRefPubMedWeb of Science
28. 28.↵
    1. Garcia-Rio F,
    2. Rojo B,
    3. Casitas R,
    4. Lores V,
    5. Madero R,
    6. Romero D,
    7. et al

    . Prognostic value of the objective measurement of daily physical activity in patients with COPD. Chest 2012;142(2):338–346.

    OpenUrlCrossRefPubMed